- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03522714
Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System for Pressure Ulcers
April 10, 2023 updated by: Robert Galiano, Northwestern University
A Prospective, Randomized Controlled Trial Evaluating the Effectiveness of the Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System in the Acute Post-Operative Management of Surgically Closed Pressure Ulcers
The primary objective is to compare the efficacy of the FIS on closure rate to the AFB after 2 weeks of operative debridement and closure.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Secondary Objectives:
- Compare the complication rate in each treatment group during the acute postoperative period (2 weeks).
- Comparisons of the inflammatory and bacterial microbiomes of pressure ulcers following surgical therapy.
- Comparisons of baseline patient characteristics and their relationship to both early and late pressure ulcer recurrence, and complication rates.
- Assessment of outcomes and complications associated with flap technique and surgeon guided descriptions of the operative closure.
- Compare the absolute costs associated with the FIS System against AFB system.
- Compare the acceptance of each system by subjects and nursing staff, including the parameter of patient comfort at 7 and 14 days postoperative.
- Assessing the incidence of complications and additional treatments needed following the two week study period.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jing Liu, MD
- Phone Number: 3126953908
- Email: jing-liu@northwestern.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Memorial Hospital Plastic Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- will be admitted as an inpatient
- is ≥ 18 years of age and ≤ 85 years of age at time of consent
- is able to provide his/her own informed consent
- is deemed by the investigators to be reasonably compliant
- has a pressure ulcer meeting criteria for stage III or IV
- has not participated in a clinical trial within the past 30 days
- has a 30-day wound history available if the wound has been previously treated
Exclusion Criteria:
- has a life expectancy of < 12 months
- is not healthy enough to undergo surgery for any reason
- has a history of radiation therapy
- is, in the opinion of the investigator, noncompliant
- has a history of > 3 closures of pressure ulcers in the same site
- has a history of a bleeding disorder
- has severe fecal incontinence
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Fluid Immersion Simulation System (FIS)
Pressure ulcer patients are assigned to Fluid Immersion Simulation System (Dolphin) after operative debridement and closure.
|
Dolphin Fluid Immersion Simulation® System Mattress will be used
Other Names:
|
Active Comparator: Air Fluidized Bed System (AFB)
Pressure ulcer patients are assigned to Air Fluidized Bed (Clinitron) after operative debridement and closure
|
Air Fluidized Bed (Clinitron) will be used.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Participants With Successful Closure of Wound at 2 Weeks After Surgery
Time Frame: 2 weeks
|
Comparison of success of closure between treatment groups.
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Complications
Time Frame: 2 weeks
|
Comparison of complication rate, including dehiscence, necrosis, maceration, and seromas between treatment groups.
These are gathered via the patient's medical chart and interaction with the Principle Investigator (their physician).
|
2 weeks
|
Differences in Quantitative Patient Survey Responses: Acceptability
Time Frame: 2 weeks
|
Differences in quantitative patient survey responses regarding acceptability.
This scale includes three subscales: 1) comfort, 2) difficulty with mobilization, and 3) pain at surgical site.
Each subscale is graded on a scale of 1-5 with 1 being "better" (i.e.
very comfortable, no difficulty, or no pain) and 5 being "worse" (i.e.
very uncomfortable, extreme difficulty, or extreme pain).
Subscales will be combined to compute a total score by averaging the sum of each of the three subscales.
The total score indicates patient acceptability on a scale of 1-5 with 1 being "better" (very acceptable) and 5 being "worse" (not acceptable).
|
2 weeks
|
Differences in Quantitative Nurse Survey Responses
Time Frame: 2 weeks
|
Differences in quantitative nurse survey responses regarding acceptability and tolerance of each therapeutic modality, including patient comfort.
This survey includes three subscales: 1) ease of use, 2) amount of training required, and 3) Time Required for Troubleshooting or Otherwise Occupied by Device.
Each subscale is graded on a scale of 1-5 with 1 being "better" (i.e.
no difficulty, no training, or no time) and 5 being "worse" (i.e.
extreme difficulty, very high amount of training, or >30 minutes a day).
Subscales will be combined to compute a total score by averaging the sum of each of the three subscales.
The total score indicates nurse acceptability on a scale of 1-5 with 1 being "better" (very acceptable) and 5 being "worse" (not acceptable).
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert D Galiano, MD, Northwestern Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 8, 2015
Primary Completion (Actual)
December 1, 2020
Study Completion (Actual)
December 1, 2020
Study Registration Dates
First Submitted
February 13, 2018
First Submitted That Met QC Criteria
April 30, 2018
First Posted (Actual)
May 11, 2018
Study Record Updates
Last Update Posted (Actual)
May 3, 2023
Last Update Submitted That Met QC Criteria
April 10, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00200584
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcer
-
The Cleveland ClinicRecruitingStage 1 Pressure Ulcer | Stage 2 Pressure UlcerUnited States, Austria
-
University GhentCare of Sweden ABCompletedPressure Ulcer | Pressure Injury | Pressure Ulcer, Buttock | Pressure SoreBelgium
-
Our Lady of Maryknoll HospitalWong Tai Sin HospitalUnknownPressure Ulcers Stage III | Pressure Ulcer, Stage IVHong Kong
-
Integra LifeSciences CorporationSt Vincent's HospitalCompletedPressure Ulcer | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
ULURU Inc.United States Department of DefenseRecruitingPressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
University of PittsburghUnited States Department of Defense; Georgia Institute of TechnologyCompletedPressure Ulcer | Pressure Injury | Pressure Ulcer, ButtockUnited States
-
Bayside HealthCompletedLength of ICU Stay | Pressure Ulcer, Area | Pressure Ulcer, Grade | Albumin Level | Risk ScoreAustralia
-
Istanbul Medipol University HospitalCompletedPressure Ulcers Stage III | Pressure Ulcer, Stage IV
-
Istituto Ortopedico RizzoliCompleted
-
EmoledRecruitingPressure Ulcer | Pressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure SoreItaly
Clinical Trials on Fluid Immersion Simulation System
-
IRCCS Policlinico S. DonatoUniversity of PaviaRecruitingMyocardial Ischemia | Sudden Cardiac Death | Anomalous Coronary Artery Origin | Anomalous Coronary Artery Arising From the Opposite Sinus | Anomalous Coronary Artery Course | Anomalous Coronary Artery With Aortic Origin and Course Between the Great ArteriesItaly
-
Ecole Polytechnique Fédérale de LausanneUniversity Hospital, GenevaNot yet recruiting
-
Prince of Songkla UniversityCompletedPre and Post Simulation Session Self-directed Learning TimeThailand
-
US Department of Veterans AffairsCompleted
-
The Cleveland ClinicCompletedCerebrospinal Fluid Drainage Catheter
-
NovaShunt AGCompletedAscites | Congestive Heart FailureSweden
-
University Health Network, TorontoUnknownPatient SimulationCanada
-
Yonsei UniversityCompletedHealthy Population | Medical School StudentKorea, Republic of
-
Universidade Estadual de LondrinaCompleted
-
Hospices Civils de LyonCompleted